| A fatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial | |
| Gadgeel, Shirish; Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassileios; Li, Wei | |
| 2015 | |
| 关键词 | Lung cancer / Oncology |
| 卷号 | 46 |
| 会议录 | EUROPEAN RESPIRATORY JOURNAL
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0903-1936 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3545071 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Gadgeel, Shirish,Soria, Jean-Charles,Felip, Enriqueta,et al. A fatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论